{"id":"https://openalex.org/W2475053745","doi":null,"title":"Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma.","display_name":"Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma.","alternate_titles":[],"publication_year":2003,"publication_date":"2003-10-01","ids":{"openalex":"https://openalex.org/W2475053745","mag":"2475053745","pmid":"https://pubmed.ncbi.nlm.nih.gov/17472274"},"language":"en","primary_location":{"id":"pmid:17472274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17472274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2475053745"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059314345","display_name":"Dimitrios T. Trafalis","orcid":"https://orcid.org/0000-0003-4066-9780","observed_orcids":["https://orcid.org/0000-0003-4066-9780"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"D T P Trafalis","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, School of Pharmacy, University of Patras, Patras, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, School of Pharmacy, University of Patras, Patras, Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110030693","display_name":"Charalampos L. Camoutsis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Camoutsis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024274095","display_name":"Panayiotis Karamanakos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Karamanakos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A Arvanitis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Arvanitis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060192256","display_name":"E Tegou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Tegou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006180337","display_name":"Nikolaos Ziras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Ziras","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110427545","display_name":"A. Athanassiou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A E Athanassiou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6171,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.6400626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"8","issue":"4","first_page":"333","last_page":"339"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.22290000319480896,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.22290000319480896,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.21979999542236328,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.21619999408721924,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hase","display_name":"HASE","score":0.8479999899864197},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8119999766349792},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9390000104904175},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9449999928474426},{"id":"https://openalex.org/keywords/liver-microsomal-metabolism","display_name":"liver microsomal metabolism","score":0.7020000219345093},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6669999957084656},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8474715352058411},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.7692363262176514},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.7661817073822021},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7579653263092041},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5954541563987732},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5305894613265991},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.4641583561897278},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.462312787771225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46145710349082947},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33075276017189026},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3045603632926941},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.267791748046875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19139468669891357},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:17472274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17472274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},{"id":"mag:2475053745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17472274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1984906472","https://openalex.org/W311116004","https://openalex.org/W2413019963","https://openalex.org/W2413916187","https://openalex.org/W2095407348","https://openalex.org/W2001310212","https://openalex.org/W2082625623","https://openalex.org/W2054734255","https://openalex.org/W2029737836","https://openalex.org/W2414528960"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"investigate":[2],"the":[3,30,44,60,76,80,104,116,131,167],"in":[4,7,24,29,41,74,88,109,158,161,166],"vitro":[5,42,89,159],"and":[6,98,145,160],"vivo":[8,75,162],"activity":[9,78,100,106,163],"of":[10,32,50,62,79,87,107,169],"an":[11],"homo-aza-steroid":[12],"alkylating":[13],"ester,":[14],"namely":[15],"13beta-hydroxy-":[16],"13alpha-amino-13,17-seco-5alpha-androstan-17-oic-13,17-":[17],"lactam-p-bis":[18],"(2-chloro":[19],"ethyl)":[20],"aminophenoxy":[21],"acetate":[22],"(HASE),":[23],"comparison":[25],"with":[26,57],"dacarbazine":[27],"(DTIC)":[28],"treatment":[31,168],"malignant":[33,52],"melanoma.":[34,170],"MATERIALS":[35],"AND":[36],"METHODS:":[37],"Cytotoxicity":[38],"was":[39,113,140],"assessed":[40],"by":[43,125,142],"MTT":[45],"assay":[46],"using":[47],"a":[48,177],"panel":[49],"6":[51],"melanoma":[53],"human":[54],"cell":[55],"lines,":[56],"or":[58],"without":[59],"presence":[61],"rat":[63],"liver":[64],"microsome":[65],"assay.":[66],"B16":[67,110],"melanoma-bearing":[68,111],"mice":[69,112,117],"were":[70],"used":[71],"to":[72,122],"evaluate":[73],"antitumor":[77,105,150],"tested":[81],"compounds.":[82],"RESULTS:":[83],"In":[84],"all":[85],"cases":[86],"screening,":[90],"HASE":[91,108,128,155,172],"displayed":[92,156],"significantly":[93,129],"higher":[94,149],"(p":[95],"<0.0001)":[96],"cytostatic":[97],"cytotoxic":[99],"than":[101,152,164],"DTIC.":[102,126,153],"Moreover,":[103],"satisfactory,":[114],"prolonging":[115],"lifespan":[118],"at":[119],"67%,":[120],"compared":[121],"43%":[123],"achieved":[124],"Furthermore,":[127],"inhibited":[130],"tumor":[132,143],"growth":[133,135],"(tumor":[134],"rate:":[136],"<42%)":[137],"as":[138,176],"this":[139],"defined":[141],"volume":[144],"weight":[146],"differences,":[147],"presenting":[148],"effect":[151],"CONCLUSION:":[154],"superior":[157],"DTIC":[165],"Thus,":[171],"may":[173],"be":[174],"considered":[175],"significant":[178],"candidate":[179],"anticancer":[180],"agent":[181],"for":[182],"further":[183],"development.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2475053745","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
